Secukinumab Provides Sustained Improvements in the Signs and Symptoms of Psoriatic Arthritis: Final 5-year Results from the Phase 3 FUTURE 1 Study

Philip J Mease*, Arthur Kavanaugh, Andreas Reimold, Hasan Tahir, Juergen Rech, Stephen Hall, Piet Geusens, Pascale Pellet, Eumorphia Maria Delicha, Luminita Pricop, Shephard Mpofu, FUTURE 1 study group

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

19 Citations (Web of Science)
Original languageEnglish
Pages (from-to)18-25
Number of pages8
JournalACR open rheumatology
Volume2
Issue number1
DOIs
Publication statusPublished - Jan 2020

Keywords

  • ANTI-INTERLEUKIN-17A MONOCLONAL-ANTIBODY
  • DOUBLE-BLIND
  • EULAR RECOMMENDATIONS
  • PREVALENCE
  • MANAGEMENT
  • THERAPIES
  • EFFICACY
  • DISEASE

Cite this